A shadow market for unapproved weight-loss medications is being driven by TikTok fitness influencers and vendors on communication apps, based on new investigations.
Experimental Treatment Gaining Popularity Via Social Media
Retatrutide, which is still in clinical trials, is being promoted by social media influencers for its alleged weight-reducing properties. Followers are encouraged to contact these accounts privately for source information, while also receiving promotional offers.
Active Trade on Social Networks
Additionally, a robust market exists on Telegram, where communities with thousands of members share comparison photos, injection guides and claims of next-day British shipping. Sellers promote the drug there before redirecting buyers to WhatsApp for transactions.
Learning About The Experimental Drug
This medication is an investigational injection created by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – GLP-1, GIP and pancreatic hormone. Early trials indicate it could assist individuals lose up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being promoted digitally as the successor to Ozempic.
Healthcare Experts Voice Worries
Nevertheless, physicians and pharmacists have warned that the distribution of what is still an unapproved medication in the UK is a cause for concern and could lead to individuals administering substances of unknown origin.
Some professionals said the popularity for retatrutide could be linked to the rising price of approved weight loss products such as Mounjaro.
Regulatory Status and Enforcement
Selling retatrutide on social media or messaging apps is illegal in the United Kingdom, as it is an unapproved medication that must not be promoted or distributed for human use under the Human Medicines Regulations 2012.
Several influencers try to sidestep the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but advertising and distribution can still breach pharmaceutical, marketing, and consumer laws, risking penalties, prosecution or imprisonment.
Service Response and Material Removal
According to TikTok, the service has taken down violative content and prohibited related keywords and query recommendations. The company stated it was dedicated to maintaining the service secure and allocating resources in enhancing enforcement strategies.
Online Marketplace Activities
Investigations also discovered groups with up to nine thousand members selling retatrutide using the platform's integrated discovery tool, which operates like a online catalog. Typing “retatrutide” instantly brings up groups with thousands of members, populated with images of slimming results, positive reviews and step-by-step instructions for mixing or injecting at home.
Within moments of entering one community, a seller posted contact information, where most transactions occur. The seller sent an guidebook and guaranteed delivery within 48 hours. When asked whether the substance was genuine, one seller said: “You can’t be sure.” Another shared a image of a supposed testing documentation. None asked about weight, medical conditions or past usage.
Item Details and Costs
Inside these communities, messages display dark colored packages with Royal Mail labels, stating to include fresh supplies. One communication read: “It took eight of us to load them this morning.”
Customers can choose between powder vials, prepared at home with sterile water, or pre-filled injectors usually sold at £160 for 20 milligrams. When asked how much time a pen should be used, vendors give contradictory answers ranging from a several days to “depends on your body”.
Platform Oversight and Security Actions
A spokesperson for Telegram stated it regularly monitored harmful content on its platform including content that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“People are administering materials they cannot confirm. Even if the science behind this drug is valid, these online versions may not contain what they claim,” said a pharmacy expert, the director of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of an online medical service connected the increase in demand to recent price rises for authorized weight-loss drugs such as Mounjaro. “With costs rising, individuals are using social media. But counterfeit treatments are extremely dangerous. You cannot know what’s contained or whether the environment they were produced in was sterile,” she said.
Her team has already encountered patients harmed by self-injection from unconfirmed sources. “We recognize the disappointment, but buying from Telegram or communication platforms is taking chances with your well-being,” stated the doctor. “These substances could be contaminated or incorrectly dosed.”
Producer Statement
A representative from the pharmaceutical company said the substance was in phase 3 clinical trials and had not been reviewed or authorized by any government authority globally. “Therefore at this point no one can market [it] for human use,” they said, noting that any item “misleadingly claiming itself as a company experimental substance not yet approved … may expose users to possibly serious medical dangers”.
